Opioids and the COVID-19 pandemic: does chronic opioid use or misuse increase clinical vulnerability?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

14 citing papers in PubMed.

1. Investigating the role of opium consumption in the severity, and outcome of COVID-19.BMC infectious diseases · 2026
   Article
2. Pharmacogenetic landscape of pain management variants among Mediterranean populations.Frontiers in pharmacology · 2024
   Article
3. Substances of abuse and their effect on SAR-CoV-2 pathogenesis.NeuroImmune pharmacology and therapeutics · 2023
   Review
4. Opioids and opioid receptors; understanding pharmacological mechanisms as a key to therapeutic advances and mitigation of the misuse crisis.BJA open · 2023
   Review
5. The development and validation of the pandemic medication-assisted treatment questionnaire for the assessment of pandemic crises impact on medication management and administration for patients with opioid use disorders.Nordisk alkohol- & narkotikatidskrift : NAT · 2023
   Article
6. The Association of Opioid Use Disorder and COVID-19, a Longitudinal Study.International journal of preventive medicine · 2022
   Article
7. Effects of fentanyl on acute locomotor activity, behavioral sensitization, and contextual reward in female and male rats.Drug and alcohol dependence · 2021
   Article
8. Therapeutic potential of long-acting opioids and opioid antagonists for SARS-CoV-2 infection.British journal of anaesthesia · 2021
   Article
9. Psychotropics and COVID-19: An analysis of safety and prophylaxis.L'Encephale · 2021
   Article
10. Investigating and addressing the immediate and long-term consequences of the COVID-19 pandemic on patients with substance use disorders: a scoping review and evidence map protocol.BMJ open · 2021
    Article
11. Anaesthesia-related drugs and SARS-CoV-2 infection.British journal of anaesthesia · 2021
    Article
12. Does opioid substitution treatment have a protective effect on the clinical manifestations of COVID-19? Comment on Br J Anaesth 2020; 125: e382-3.British journal of anaesthesia · 2021
    Article
13. A double-edged sword of using opioids and COVID-19: a toxicological view.Substance abuse treatment, prevention, and policy · 2020
    Article
14. Impact of the COVID-19 pandemic on the pharmacological, physical, and psychological treatments of pain: findings from the Chronic Pain & COVID-19 Pan-Canadian Study.Pain reports
    Article

Corrections and comments

• Commented on by
  Does opioid substitution treatment have a protective effect on the clinical manifestations of COVID-19? Comment on Br J Anaesth 2020; 125: e382-3.2021

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as